Anzeige
Mehr »
Login
Dienstag, 12.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
1.087 Leser
Artikel bewerten:
(2)

INFORMA MARKETS - ENGINEERING: BIOMEDevice Silicon Valley Concludes With 15% Growth in Attendees

Finanznachrichten News

The leading Medtech event brought together industry professionals to discuss the future of the medical device industry.

SANTA CLARA, CA / ACCESSWIRE / November 28, 2023 / BIOMEDevice Silicon Valley, the leading West Coast exhibition for medical device companies and manufacturers, wrapped this month with over 1,400 attendees, reporting a 15% growth from 2022. The annual event connected influential and impactful medtech and life science professionals shaping the industry's landscape.

BIOMEDevice Silicon Valley featured over 40 educational speakers focused on challenges and solutions surrounding the medtech industry. Conference attendees had access to nine educational tracks including device security, product design, machine learning, policy and regulations. Topics included FDA approvals for medical device start-ups, fundamentals of X-ray sterilization and generative artificial intelligence.

Y-Combinator and Axiom Space female visionary speakers, Surbhi Sarna and Pearly Pandya respectively, presented groundbreaking case studies and keynoted the two-day conference where each addressed unique entrepreneurial development and funding challenges of early-stage ovarian cancer detection as well as the next international space station manufacturing biomedical products in space.

Surbhi Sarna, Partner and Author at Y-Combinator and CEO, Founder of nVision, states, "Inspiring innovation in medtech and healthcare starts with the power of conversation. Being an advocate and sharing my story as a patient and entrepreneur at events such as BIOMEDevice Silicon Valley sparks collaboration that can propel our industry towards researching and funding more life-saving advancements."

"In-space manufacturing represents the next frontier for medical innovation," says Pearly Pandya, In-Space Manufacturing for Biomedical Applications at Axiom Space. "Presenting Axiom Space's microgravity research to likeminded medical industry professionals in the thriving technology landscape of Silicon Valley can help shape the future of biomedical advancements."

With significant surges in research and development, Silicon Valley is a hub for pioneering advancements in medtech and is recognized as a region of substantial funding and start-up development. In partnership with California Life Sciences, the state's most influential and impactful life sciences organization, BIOMEDevice Silicon Valley hosted a Master Class Conference, Start-up Stadium and Start-up Pavilion, to provide a platform for emerging medical device companies from Northern California to gain exposure and credibility in front of thousands of industry leading potential suppliers, investors and engineers.

"In the dynamic landscape of medical technology, Silicon Valley stands at the forefront of innovation, driving transformative solutions with impact shaping the future of our healthcare," says Adrienne Zepeda, BIOMEDevice Event Director, Informa Markets Engineering. "Highlighting revolutionary products, BIOMEDevice is the Bay Area's stage for discovering and connecting with the most transformative medical solutions available on the market now and upcoming. The expert insights provided here showcase the creative intelligence that fuels inspiration and ingenuity of device manufacturing."

Over 175 exhibitors were represented on the expo floor, showcasing a broad range of solutions and products including sensor-driven micromedical devices, laser cutting, linear and rotary motion components and high-performance metal parts. Industry leading companies in attendance included Hiwin, Matrix Plastic Products, Nelson Labs, Pacific BioLabs, Senso Medical, Starfish Medical, Qosina and Velentium, among others.

BIOMEDevice Silicon Valley will return to the Santa Clara Convention Center Nov. 20-21, 2024.

Medical Design and Manufacturing (MD&M) West, Informa Markets Engineering's West Coast based medtech event, is taking place Feb. 6-8, 2024. For more information, please visit www.imengineeringwest.com.

About Informa Markets Engineering:??

Informa Markets Engineering portfolio, a subsidiary of Informa plc (LON:INF), is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit?www.informamarkets.com.??

Media Contact:??

Jordan Douglas??
Informa Markets Engineering??
pr.ime(@)informa.com

SOURCE: Informa Markets Engineering??

View source version on accesswire.com:
https://www.accesswire.com/810836/biomedevice-silicon-valley-concludes-with-15-growth-in-attendees

© 2023 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.